D

Dong-A ST Co Ltd
KRX:170900

Watchlist Manager
Dong-A ST Co Ltd
KRX:170900
Watchlist
Price: 59 500 KRW -0.83% Market Closed
Market Cap: 534.5B KRW
Have any thoughts about
Dong-A ST Co Ltd?
Write Note

Dong-A ST Co Ltd
Accrued Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Dong-A ST Co Ltd
Accrued Liabilities Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Accrued Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
D
Dong-A ST Co Ltd
KRX:170900
Accrued Liabilities
â‚©55.4B
CAGR 3-Years
19%
CAGR 5-Years
5%
CAGR 10-Years
13%
Yuhan Corp
KRX:000100
Accrued Liabilities
â‚©37.5B
CAGR 3-Years
213%
CAGR 5-Years
36%
CAGR 10-Years
48%
SK Biopharmaceuticals Co Ltd
KRX:326030
Accrued Liabilities
â‚©71.3B
CAGR 3-Years
25%
CAGR 5-Years
24%
CAGR 10-Years
N/A
Hanmi Pharm Co Ltd
KRX:128940
Accrued Liabilities
â‚©52.7B
CAGR 3-Years
23%
CAGR 5-Years
11%
CAGR 10-Years
15%
S
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
Accrued Liabilities
â‚©10.9B
CAGR 3-Years
9%
CAGR 5-Years
5%
CAGR 10-Years
14%
C
Celltrion Pharm Inc
KOSDAQ:068760
Accrued Liabilities
â‚©313m
CAGR 3-Years
-47%
CAGR 5-Years
-26%
CAGR 10-Years
-17%
No Stocks Found

Dong-A ST Co Ltd
Glance View

Market Cap
511.6B KRW
Industry
Pharmaceuticals

Dong-A ST Co., Ltd. engages in the manufacture and sale of pharmaceutical products. The company is headquartered in Seoul, Seoul. The company went IPO on 2013-04-08. The firm is involved of the manufacturing and sale of gastric mucosal protective agents, antihistamines, ischemic modifiers, antithrombotic agents, functional dyspepsia, hyperlipidemia, growth hormone, peptic ulcer treatments, cerebral metabolism improvement and hypertension treatments. The company produces and sells diagnostic reagents for hepatitis E, I, A and B. In addition, it is engaged in the production and sale of medical devices including implants for artificial joint and maxillofacial surgery. The firm distributes its products in domestic and overseas markets such as Brazil, Turkey and Cambodia.

Intrinsic Value
96 510.53 KRW
Undervaluation 38%
Intrinsic Value
Price
D

See Also

What is Dong-A ST Co Ltd's Accrued Liabilities?
Accrued Liabilities
55.4B KRW

Based on the financial report for Sep 30, 2024, Dong-A ST Co Ltd's Accrued Liabilities amounts to 55.4B KRW.

What is Dong-A ST Co Ltd's Accrued Liabilities growth rate?
Accrued Liabilities CAGR 10Y
13%

Over the last year, the Accrued Liabilities growth was 65%. The average annual Accrued Liabilities growth rates for Dong-A ST Co Ltd have been 19% over the past three years , 5% over the past five years , and 13% over the past ten years .

Back to Top